

Product description
MPL proto-oncogene, thrombopoietin receptor(MPL) Homo sapiens In 1990 an oncogene, v-mpl, was identified from the murine myeloproliferative leukemia virus that was capable of immortalizing bone marrow hematopoietic cells from different lineages.
Source
Rabbit
Applications
WB,IHC,ELISA
Reactivity
Human,Mouse,Rat
Dilution
WB: 1/500 - 1/2000. IHC: 1/100-1/300. ELISA: 1/20000. Not yet tested in other applications.
Storage
-20°C/1 year
Specificity
CD110 Polyclonal Antibody detects endogenous levels of CD110 protein.
Source/Purification
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Immunogen
Synthesized peptide derived from Thrombopoietin receptor at AA range: 321-370
Uniprot No
P40238
Alternative names
MPL; TPOR; Thrombopoietin receptor; TPO-R; Myeloproliferative leukemia protein; Proto-oncogene c-Mpl; CD110
Form
Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Clonality
Polyclonal
Background
MPL proto-oncogene, thrombopoietin receptor(MPL) Homo sapiens In 1990 an oncogene, v-mpl, was identified from the murine myeloproliferative leukemia virus that was capable of immortalizing bone marrow hematopoietic cells from different lineages.
Other
Gene_name: MPL ; Protein_name: Thrombopoietin receptor; Expression:
Mol.Wt (Da)
69,40 kD
Concentration
1 mg/ml
-
Promotion
-
Order
-
Online message
-
Help center